Look stakeholder perspectives medicare advantage reform

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 08 Oct, 22:46 UTC

A survey of 52 experts spanning researchers, the Medicare Advantage industry, patient advocates and policymakers wasn't able to identify a single policy proposal that would be received wholeheartedly by all three groups.